Literature DB >> 12840895

Effect of astragalus on the endothelin in rats with acute lung injury.

X Liu1, C Huang.   

Abstract

The effect of astragalus on the endothelin in serum and lung of the rats with acute lung injury was studied. The results demonstrated that the concentration of endothelin in the lung of the rats in therapy group was lower than that of the injured rats (64.36 +/- 5.37 ng/L vs 103.32 +/- 4.99 ng/L, P < 0.001), and level of serum endothelin was also lower than that of the injured rats (85.35 ng/L vs 113.35 ng/L, P < 0.01). PaO2, serum SOD, lung coefficient, ratio of lung wet weight/dry weight in two groups were also significantly different (P < 0.01) respectively, and the lung pathological injury in the treatment group were less than that of injury group. So it is concluded that astragalus could inhibit the increase of serum and lung endothelin, thereby playing a protective role in the rats with acute lung injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 12840895     DOI: 10.1007/bf02887735

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  4 in total

1.  Release of endothelin in the oleic acid-induced respiratory distress syndrome in rats.

Authors:  T Simmet; S Pritze; K I Thelen; B A Peskar
Journal:  Eur J Pharmacol       Date:  1992-02-18       Impact factor: 4.432

2.  Surfactant proteins-A and -B are elevated in plasma of patients with acute respiratory failure.

Authors:  I R Doyle; A D Bersten; T E Nicholas
Journal:  Am J Respir Crit Care Med       Date:  1997-10       Impact factor: 21.405

3.  Endothelin-1-induced increases in microvascular permeability in isolated, perfused rat lungs requires leukocytes and plasma.

Authors:  E Helset; J Kjaeve; A Hauge
Journal:  Circ Shock       Date:  1993-01

4.  Alterations in circulating vasoactive substances in the critically ill--a comparison between survivors and non-survivors.

Authors:  J Boldt; T Menges; D Kuhn; C Diridis; G Hempelmann
Journal:  Intensive Care Med       Date:  1995-03       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.